Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UniFirst Likely To Report Higher Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Author: Avi Kapoor | March 26, 2024 08:07am

UniFirst Corporation (NYSE:UNF) is expected to release earnings results for its second quarter, before the opening bell on March 27, 2024.

Analysts expect the Wilmington, Massachusetts-based company to report quarterly earnings at $1.43 per share, up from $1.39 per share in the year-ago quarter. UniFirst is projected to report quarterly revenue of $587.84 million, according to data from Benzinga Pro.

On Jan. 3, UniFirst said first-quarter sales grew 9.5% Y/Y to $593.5 million, beating the consensus of $589.6 million.
UniFirst shares fell 0.8% to close at $168.69 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Barclays analyst Manav Patnaik maintained an Equal-Weight rating and boosted the price target from $160 to $180 on Feb. 29, 2024. This analyst has an accuracy rate of 76%.
  • Baird analyst Andrew Wittmann downgraded the stock from Outperform to Neutral with a price target of $185 on Jan. 4, 2024. This analyst has an accuracy rate of 80%.
  • JP Morgan analyst Andrew Steinerman maintained an Underweight rating and increased the price target from $150 to $160 on Oct. 19, 2023. This analyst has an accuracy rate of 81%.
  • UBS analyst Joshua Chan initiated coverage on the stock with a Neutral rating and a price target of $185 on June 1, 2023. This analyst has an accuracy rate of 76%.

 

Read This Next: Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'

Posted In: UNF

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist